Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
BMC Medicine|July 27, 2018
Medications that reduce emergency hospital admissions: an overview of systematic reviews and prioritisation of treatmentsNiklas Bobrovitz, Carl Heneghan, Igho Onakpoya, et al.
Skin Health and Disease|March 24, 2025
Amitriptyline for the prevention of post herpetic neuralgia: study protocol for the ATHENA studySian Wells, Stephanie J MacNeill, Yumeng Liu, et al.
Pain|October 16, 2015
Neuropathic pain phenotyping by international consensus (NeuroPPIC) for genetic studies: a NeuPSIG systematic review, Delphi survey, and expert panel recommendationsOliver van Hecke, Peter R Kamerman, Nadine Attal, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|April 20, 2022
Colchicine for COVID-19 in the community (PRINCIPLE): a randomised, controlled, adaptive platform trialJienchi Dorward, Ly-Mee Yu, Gail Hayward, et al.
Hypertension (Dallas, Tex. : 1979)|December 16, 2020
Association Between Blood Pressure Control and Coronavirus Disease 2019 Outcomes in 45 418 Symptomatic Patients With Hypertension: An Observational Cohort StudyJames P Sheppard, Brian D Nicholson, Joseph Lee, et al.
The Lancet. Respiratory Medicine|July 30, 2021
Doxycycline for community treatment of suspected COVID-19 in people at high risk of adverse outcomes in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trialChristopher C Butler, Ly-Mee Yu, Jienchi Dorward, et al.
The Journal of Infection|August 31, 2024
Favipiravir for COVID-19 in adults in the community in PRINCIPLE, an open-label, randomised, controlled, adaptive platform trial of short- and longer-term outcomesFd Richard Hobbs, Oghenekome A Gbinigie-Thompson, Milensu Shanyinde, et al.
BMJ Open|June 19, 2021
Platform Randomised trial of INterventions against COVID-19 In older peoPLE (PRINCIPLE): protocol for a randomised, controlled, open-label, adaptive platform, trial of community treatment of COVID-19 syndromic illness in people at higher riskGail Hayward, Christopher C Butler, Ly-Mee Yu, et al.
Lancet (London, England)|August 13, 2021
Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trialLy-Mee Yu, Mona Bafadhel, Jienchi Dorward, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|January 16, 2024
Cost-utility analysis of molnupiravir for high-risk, community-based adults with COVID-19: an economic evaluation of the PANORAMIC trialMay Ee Png, Victoria Harris, Jenna Grabey, et al.
Pageof 5